New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

AbbVie Inc.

ABBV

Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.

Revenue
+10.3%
EPS
+2,270.0%
Free cash flow
+9.97%
Total debt
+17.7%

Quarter to September 2026, against a year earlier

288.50 4.99 +1.76%
Market cap
$501.2B
P/E
48.8×
Fwd P/E FY26e
37.6×
Dividend yield
2.44%
F-score
8/9
ROIC
20.2%
Net debt / EBITDA
2.6×
Payout ratio
1.2×

AbbVie Inc. (ABBV) Return on equity

Alert me on Return on equity

AbbVie Inc.'s return on equity over the twelve months to Sep 30, 2026 was −288.7%, down 6444.6 percentage points from fiscal 2025 (6,155.9%). Over the past ten years it has ranged from −339.6% (fiscal 2018) to 6,155.9% (fiscal 2025) — the current reading is the highest in ten years. That is below the Drug Manufacturers General industry median of 20.0% and below the Healthcare sector median of −27.3%.

Return on equity, annual

Embed this chart

Annual newest first

Period Return on equity Change (points)
FY2025 6,155.9% 6,094.29
FY2024 61.6% 26.77
FY2023 34.8% (37.19)
FY2022 72.0% (8.89)
FY2021 80.9% (106.55)
FY2020 187.5% 282.31
FY2019 −94.9% 244.76
FY2018 −339.6% (448.71)
FY2017 109.1% (29.66)
FY2016 138.8% (42.15)

Against its own ten years

Low −339.6% High 6,155.9%
Ten-year median 80.9%
Current reading's percentile 100

Return on equity against peers

Company Return on equity
LLY Eli Lilly and Company compare 86.0%
AMGN Amgen Inc. compare 78.4%
NVS Novartis AG compare 24.4%
AZN AstraZeneca PLC compare 22.6%
JNJ Johnson & Johnson compare 20.0%
MRK Merck & Co., Inc. compare 5.07%
PFE Pfizer Inc. compare 4.42%
GILD Gilead Sciences, Inc. compare −22.5%
ABBV AbbVie Inc. −288.7%
Drug Manufacturers General industry median 20.0%
Healthcare sector median −27.3%
Market median 1.88%

What Return on equity is

ROE shows how much profit a company earns for its shareholders on the equity they have in the business.

Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)

The full definition of Return on equity →

More on ABBV